The importance of myocarditis in Covid-19
Katayoun Haryalchi1, Sepehr Olangian-Tehrani2, Seyed Mohammad Asgari Galebin3
1Reproductive Health Research Center, Al-zahra Hospital, School of Medicine Guilan University of Medical Sciences Rasht Iran.
Insights
The Covid-19 virus can cause serious heart complications, including myocarditis. This study reviews how the virus impacts myocarditis and its associated cardiac injuries.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- The novel coronavirus (Covid-19) outbreak poses a significant public health threat.
- Covid-19 is associated with cardiovascular complications, notably acute myocardial injury and myocarditis.
- Myocarditis symptoms include chest pain, tachycardia, and chest tightness, potentially leading to cardiogenic shock.
Purpose of the Study:
- To assess the effects of Covid-19 on myocarditis.
- To review the mechanisms of cardiac injury in Covid-19 patients.
- To discuss current treatment protocols and research gaps.
Main Methods:
- This study employed a narrative review methodology.
- Literature search was conducted on Covid-19 and myocarditis.
- Existing research on cardiac injury mechanisms and treatment was synthesized.
Main Results:
- Cardiac injury in Covid-19 may result from direct viral myocardial infection, hypoxemia, or systemic inflammation.
- Pathologic processes include viral binding to ACE2 receptors, systemic inflammation, and thrombosis.
- There is ongoing debate regarding corticosteroid use in active Covid-19 myocarditis.
Conclusions:
- Covid-19 presents a multifaceted threat to cardiovascular health, particularly concerning myocarditis.
- Further research is crucial to understand and manage Covid-19-related cardiac complications.
- Clarifying treatment strategies, such as corticosteroid use, is essential.
Background:
The outbreak of Covid-19 is a real threat to public health. It causes cardiovascular complications such as acute myocardial injury and myocarditis. Symptoms of myocarditis vary from chest pain, tachycardia, or chest tightness. Inotropes and/or vasopressors and mechanical ventilation are the protocols for cardiogenic shock in patients with myocarditis. Some previous studies stated that the mechanism of cardiac injury is not well defined but, it can be due to direct myocardial infection, respiratory failure or hypoxemia, and indirect injury from systemic inflammatory response separately or all three factors together. The pathologic processes included direct myocardial injury by virus binding to ACE2, systemic inflammation, altered myocardial demand-supply ratio, and plaque and coronary thrombosis. There are disagreements on the usage of corticosteroids in active-infection myocarditis. As everyday new complications of Covid-19 appear, there is a need for further research to overcome them.
Aims:
This narrative study aimed to assess the effect of Covid-19 on myocarditis.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis IV: Nursing Management
Pericarditis I: Introduction
Endocarditis I: Introduction


